Targeting tumor metastasis by regulating Nm23 gene expression

V Vinod Prabhu1, Siddikuzzaman, V M Berlin Grace

  • 1Department of Biotechnology, Karunya University, Karunya Nagar, Coimbatore, Tamil Nadu, India.

Insights

The Nm23 gene acts as a metastasis suppressor, impacting cancer spread. Reduced Nm23 expression, especially with p53 gene alterations, increases metastatic potential, highlighting Nm23 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Nm23 gene is a key metastasis suppressor gene (MSG) identified in melanoma.
  • Nm23 is highly conserved across species, suggesting a crucial role in development.
  • Its expression levels correlate with metastatic potential in various tumors.

Purpose of the Study:

  • To review the role of the Nm23 gene in cancer progression.
  • To explore Nm23 as a potential novel target for cancer therapy.

Main Methods:

  • Literature review focusing on Nm23 gene function and expression.
  • Analysis of studies linking Nm23 expression to metastatic potential.
  • Examination of Nm23-H1's enzymatic activity (3'-5' exonuclease).

Main Results:

  • Nm23 expression is linked to reduced or increased metastatic potential in tumors.
  • Alterations in the p53 gene combined with reduced Nm23 expression correlate with higher metastasis rates.
  • Nm23-H1 exhibits 3'-5' exonuclease activity.

Conclusions:

  • Nm23 plays a significant role in regulating cancer metastasis.
  • The Nm23 gene represents a promising therapeutic target for cancer treatment.
  • Further research into Nm23's mechanisms could lead to novel anti-metastatic strategies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...